Literature DB >> 25695888

Impact of corticosteroid-binding globulin deficiency on pregnancy and neonatal sex.

Jing-Hui Lei1, Xiaokui Yang, Sha Peng, Ying Li, Caroline Underhill, Cheng Zhu, Hai-Yan Lin, Hongmei Wang, Geoffrey L Hammond.   

Abstract

CONTEXT: Plasma corticosteroid-binding globulin (CBG) transports cortisol but high progesterone levels at the maternal-fetal interface can displace cortisol from its steroid-binding site. A secretion-deficient CBG mutant (A51V) in ∼1 of 36 Chinese causes low circulating CBG levels.
OBJECTIVE: Assess the implications of a CBG deficiency on pregnancy outcomes. PARTICIPANTS AND
DESIGN: From 1978 Chinese women screened at 12-16 weeks' gestation, 50 A51V carriers were identified and 46 were followed with 60 controls throughout pregnancy. Blood samples from another 2051 pregnant women were obtained at term to determine the secondary sex ratio (SSR) of newborns in an extended cohort (n = 101) of A51V mothers. OUTCOME MEASURES AND
RESULTS: Among women recruited at 12-16 weeks' gestation, serum CBG increased progressively during pregnancy but was lower (P < .0001) in heterozygous A51V carriers than controls. Two women homozygous for A51V had very low serum CBG but their pregnancies progressed normally. The A51V mothers did not differ from controls in body mass index, gestational age at delivery, duration of parturition, blood pressure, gravidity, infant birth weight and size, or placental weights, and reported no unusual clinical symptoms. Peripheral CBG and progesterone levels correlated (r = 0.459) during first and second trimesters. Progesterone levels were much higher in intervillous blood and correlated (r = 0.637) with CBG levels. A female-skewed SSR in newborns of A51V mothers (0.77) differed (P < .05) from the SSR (1.17) in a reference cohort.
CONCLUSIONS: CBG influences progesterone levels in peripheral blood and at the maternal-fetal interface. The female-skewed SSR suggests that male fetal survival is compromised in CBG-deficient mothers.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25695888     DOI: 10.1210/jc.2014-4254

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  7 in total

1.  Pyrexia and acidosis act independently of neutrophil elastase reactive center loop cleavage to effect cortisol release from corticosteroid-binding globulin.

Authors:  Emily J Meyer; David J Torpy; Anastasia Chernykh; Morten Thaysen-Andersen; Marni A Nenke; John G Lewis; Harinda Rajapaksha; Wayne Rankin; Steven W Polyak
Journal:  Protein Sci       Date:  2020-11-04       Impact factor: 6.725

2.  Differential Effects of Estrogen on Corticosteroid-Binding Globulin Forms Suggests Reduced Cleavage in Pregnancy.

Authors:  Marni A Nenke; Anna Zeng; Emily J Meyer; John G Lewis; Wayne Rankin; Julie Johnston; Svjetlana Kireta; Shilpanjali Jesudason; David J Torpy
Journal:  J Endocr Soc       Date:  2017-02-13

3.  Functional implications of corticosteroid-binding globulin N-glycosylation.

Authors:  Marc Simard; Caroline Underhill; Geoffrey L Hammond
Journal:  J Mol Endocrinol       Date:  2017-12-22       Impact factor: 5.098

Review 4.  Avian corticosteroid-binding globulin: biological function and regulatory mechanisms in physiological stress responses.

Authors:  Hai-Yan Lin; Gang Song; Fumin Lei; Dongming Li; Yanhua Qu
Journal:  Front Zool       Date:  2021-04-29       Impact factor: 3.172

5.  Gq/11-Dependent Changes in the Murine Ovarian Transcriptome at the End of Gestation.

Authors:  Courtney Waite; Rachel Mejia; Mario Ascoli
Journal:  Biol Reprod       Date:  2016-02-03       Impact factor: 4.285

Review 6.  Plasma steroid-binding proteins: primary gatekeepers of steroid hormone action.

Authors:  Geoffrey L Hammond
Journal:  J Endocrinol       Date:  2016-04-25       Impact factor: 4.286

7.  Substrates and Clearance Products of Fetal Adrenal Glucocorticoid Synthesis in Full-Term Human Umbilical Circulation.

Authors:  Heather E Edwards; Katherine E Wynne-Edwards
Journal:  J Endocr Soc       Date:  2019-12-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.